The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.

Mar 3, 2025 0
Mar 3, 2025 0
Mar 1, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 3, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 4, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 3, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 5, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 4, 2025 0
Mar 3, 2025 0
Mar 3, 2025 0
Feb 28, 2025 0
Feb 27, 2025 0
Mar 4, 2025 0
Mar 3, 2025 0
Feb 28, 2025 0
Feb 28, 2025 0
Feb 28, 2025 0
Feb 26, 2025 0
Feb 20, 2025 0
Or register with email
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.